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Chiral amines have proven to be powerful building blocks for defining new pharmaceutical and agrochemicals 
due to their high density of structural information. In this light, the reduction of prochiral C=N double bonds is a 
well-established route in synthetic chemistry due to the easy accessibility of imines from their ketone precursors 
with the asymmetric addition of hydrogen or a hydride as the key stereo-differentiating step. Recently, we have 
witnessed remarkable advances in the enzyme-catalyzed asymmetric reduction of imines by NADPH-dependent 
imine reductases (IREDs).[1,2] Imine reductases were presented that catalyze the asymmetric reduction of 
various imines and the chemo- and stereoselective reductive amination as a useful method for the preparation 
of amines derived from aldehydes and ketones.[3,4] 
 
 
Most of reported cases involving the relaxing of 
switching of cofactor specificity have utilized 
sequence alignments and structural 
information, typically from either X-ray 
crystallography or homology modeling, in 
identifying amino acid residues likely to affect 
the specificity. The utilization of the ‘Cofactor 
Specificity Reversal–Structural Analysis and 
Library Design’ (CSR-SALAD)[5] tool and further 
structure analysis enabled us to substantially 
alter the cofactor specificity of the imine 
reductase from Myxococcus stipitatus from 
NADPH to NADH. A 96-well plate screen was 
developed and variants were screened based 
on the spectral signature of reduced 
nicotinamide. Replacement of four residues in 
the nicotinamide cofactor phosphate-binding 
site in combination resulted in imine reductase 
variants with reversed cofactor specificity. 
Furthermore, we have constructed imine 
reductase variants that recovered the catalytic 
efficiency. The kinetic parameters of WT and 
best variants were determined to further validate 
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Figure 1 – Switching the NADPH cofactor specificity of an 
imine reductase 
